Key Highlights

  • Future Vision II's reported 17.9% gain was measured against a stale Wednesday close since the stock did not trade at all on Thursday; against the prior Monday, shares actually fell 3.1% for the week.
  • The real story was a two-day crash to 28% below trust value after the company filed for up to twelve monthly extensions, admitting its approved Merger might not close by the September 2026 deadline.
  • With 65.4% of public shares tendered for Redemption , remaining trust cash of roughly $21.8 million may fall short of Nasdaq 's $25 million minimum listing threshold for China-based companies.

A gain that is not what it looks like

Future Vision II (NASDAQ:FVN) closed at $11.00 on Friday 31 July 2026, up 17.90%. The comparison is against Wednesday 29 July's close of $9.33, because on Thursday 30 July the stock did not trade at all: zero shares, no prints.

Set against Monday 27 July's close of $11.35, the stock finished the week down 3.1%. And $11.00 sits almost exactly on the cash held in the trust account, reported at roughly $10.97 a share as of 23 July, a premium of 0.27%. This was not a SPAC breaking out on speculation. It was a SPAC returning to trust value after falling below it.

There is no speculative premium to explain: the shares are trading essentially at cash value.

The real anomaly was Tuesday

On 28 July the stock fell 21.59% to $8.90 on 114,130 shares. On 29 July it traded as low as $7.90, roughly 28% below the cash a holder could redeem for. For a SPAC with intact redemption rights that is economically irrational, and it is the genuine puzzle of the week.

The trigger is identifiable. On 28 July the company filed a preliminary proxy statement seeking authority for up to twelve monthly extensions, pushing its outside date from September 2026 to September 2027. The board's stated reason was blunt: it is "not certain whether there will be sufficient time before September 13, 2026" to satisfy the remaining closing conditions. "including the approval of the listing of ordinary shares of the post-combination company by The Nasdaq stock market LLC."

That filing came five days after shareholders approved the merger. The market read it as an admission that an approved deal might not close, and sold.

The SPAC and its target

Future Vision II is a Cayman Islands blank-cheque company operating from Shanghai, sponsored by HWei Super Speed Co., Ltd, chaired by Danhua Xu. It raised $57.5 million in September 2024 selling 5,750,000 units at $10.00, each unit comprising one share and a right to one-tenth of a share. It issued no warrants. Total shares outstanding are 7,544,000 including founder, private Placement and representative shares.

Its target is MicroTouch Technology, a Hong Kong information-technology Business running two divisions: an algorithmic real-time traffic-matching platform connecting traffic suppliers with digital Advertising Demand , and custom enterprise software development. The agreement, signed 16 January 2026, values MicroTouch at $90 million, supported by a third-party appraisal of $90.9 million to $92.0 million. There is no variable interest entity structure. This is the sponsor's second attempt, a deal with VIWO Technology announced in November 2024 was terminated on 29 December 2025.

The redemption arithmetic

Shareholders approved the merger on 23 July by 5,688,865 votes to 123,691, on an 80.6% quorum. But 3,758,515 public shares (65.4% of the public float) were tendered for redemption, worth roughly $41.2 million. If the deal closes, about 1,991,485 public shares remain and roughly $21.8 million stays in trust.

That figure is the problem. Nasdaq requires a minimum of $15 million in unrestricted publicly held shares for an initial listing, rising to $25 million where the China-based company designation applies. On the maximum-redemption arithmetic, $21.8 million clears the first test and fails the second, which is a plausible, though unconfirmed, explanation for why listing approval has not arrived.

The financial position

The trust held $61.76 million at 31 March 2026 and $62.70 million by late June, with cash outside trust of $873,737 and positive Working Capital of $558,479. The 2025 accounts show Net Income of $2,070,450. Entirely trust interest of $2,429,893 less $391,049 of operating costs, not a business result. Unusually for a SPAC, the deferred Underwriting fee is payable in shares rather than cash, so there is no deferred cash Liability . The auditor's report carries substantial doubt about the company's ability to continue as a Going Concern .

The bull case

At $11.00 against trust of $10.97, a buyer is paying three cents for optionality on a deal that shareholders have already approved and a board that has already been elected. The sponsor has funded five consecutive monthly extensions at $191,475 each without asking public holders to vote or redeem, and those notes are forgiven if no combination occurs, the sponsor's capital is genuinely at risk. If the extension passes, the monthly cost drops to the lesser of $65,000 or $0.0333 a share, a roughly two-thirds reduction. Redemption rights remain available at the August vote, so a holder who files correctly can still take cash.

The bear case

Nasdaq has not approved the post-combination listing, and the board has said so in a public filing. The charter's hard outside date is 13 September 2026; the currently funded deadline is 13 August. A 65.4% redemption strips the trust from roughly $62 million to $21.8 million, materially reducing the cash MicroTouch receives and threatening the listing threshold. No audited financial figures for MicroTouch were locatable in the registration materials, a $90 million Enterprise value with no verified Revenue base.

And the trading itself is a warning. Zero Volume on 30 July; a 53% intraday range on 29 July; typical quiet sessions of a few hundred shares. The floor at trust value is only enforced for holders who actually exercise redemption rights before the 26 August deadline. Anyone buying at $11.00 in the open market and missing that deadline has no floor at all: as the $7.90 print demonstrated.

Valuation

The screener's price-to-earnings ratio of 290 on Earnings of $0.04 is meaningless, and the underlying figures are irreconcilable across data providers. There are no operating earnings; the income is trust interest that belongs to redeeming shareholders. The only valuation that applies to a pre-combination SPAC is the premium or discount to trust, and at $11.00 against $10.97 that premium is three cents.

What to watch

Three dates. 13 August is when the current funded deadline expires and another $191,475 sponsor deposit is required. 26 August at 5pm Eastern is the redemption election deadline for the extension vote. 13 September is the charter's hard outside date, beyond which mandatory Liquidation applies unless the extension passes. The extension meeting date itself was left blank in the preliminary filing. The clearest upside is Nasdaq approving the listing and the deal closing. The clearest downside is a second failed target in eight months.

Key Investor Takeaways

  • The 17.9% is measured across a non-trading day: The shares did not trade at all on 30 July 2026. The gain is calculated against the 29 July close of $9.33. Against Monday's close of $11.35, the stock finished the week down 3.1%.
  • There is no speculative premium: At $11.00 against trust value of roughly $10.97 a share, the premium is 0.27%. The stock is trading at cash, not above it.
  • The real anomaly was the crash: On 28 July the stock fell 21.59% to $8.90 and on 29 July traded as low as $7.90; roughly 28% below the cash a holder could redeem for, which is economically irrational for a SPAC with intact redemption rights.
  • A proxy filing triggered it: On 28 July the company sought authority for up to twelve monthly extensions, with the board stating it is "not certain whether there will be sufficient time before September 13, 2026" to close; including because Nasdaq has not approved the post-combination listing.
  • The merger was already approved: Shareholders voted 5,688,865 to 123,691 in favour on 23 July 2026, five days before the extension filing.
  • Redemptions strip most of the trust: 3,758,515 public shares (65.4% of the public float) were tendered, worth roughly $41.2 million. If the deal closes, about $21.8 million remains, against a Nasdaq threshold that may be $25 million.
  • This is the second target: A deal with VIWO Technology announced in November 2024 was terminated on 29 December 2025. The MicroTouch agreement was signed on 16 January 2026.

Upcoming Catalysts

  • 13 August 2026; the currently funded business combination deadline. A further $191,475 sponsor deposit is required to extend it by one month.
  • 26 August 2026; the redemption election deadline for the extension meeting. Holders who wish to take cash rather than remain through a further year must act by then.
  • The extension Shareholder meeting itself, scheduled for August 2026 in Shanghai. The specific date was left blank in the preliminary proxy statement and will be fixed in the definitive version.
  • 13 September 2026; the hard outside date under the current charter, beyond which mandatory liquidation applies unless the extension proposals pass. The proposed new outside date is 13 September 2027.
  • Nasdaq's decision on the initial listing application for the post-combination company, described by the board as an outstanding closing condition. No decision date has been announced.
  • Closing of the MicroTouch business combination. No expected closing date has been publicly announced, and no completion filing had been made as of 1 August 2026.

Principal Risks

  • Nasdaq has not approved the post-combination listing, an unsatisfied closing condition the board called out explicitly. Post-redemption public float of roughly $21.8 million may fall short of the $25 million threshold applicable to China-based company designations.
  • The charter's hard deadline of 13 September 2026 triggers mandatory liquidation if unmet. The currently funded deadline is 13 August 2026.
  • The board has stated it is not certain the transaction can close in time; an unusually direct admission of closing risk five days after winning the shareholder vote.
  • Redemptions of 3,758,515 shares, or 65.4% of the public float, cut the trust from roughly $62 million to $21.8 million on closing, reducing the cash delivered to the target and threatening listing thresholds. Further redemptions are available at the August vote.
  • This is the sponsor's second target. The prior VIWO Technology transaction, signed November 2024, was terminated in December 2025.
  • No audited financial figures for MicroTouch were locatable in the registration materials; a $90 million enterprise value with no verified revenue base.
  • PRC and Hong Kong Regulatory Risk , including the possibility of mainland oversight extending to Hong Kong-based companies, data security requirements, and the enforceability of US judgments against a Cayman issuer with Hong Kong operations and China-based officers.
  • National security review risk given the foreign sponsor, flagged in the registration statement.
  • Governance conflict: a sponsor principal holds a concurrent role at another blank-cheque company, disclosed in the Annual Report .
  • Extreme illiquidity: zero trades on 30 July 2026, a 53% intraday range on 29 July, and typical quiet sessions of a few hundred shares. A single order can move the quote by 20%.
  • The auditor's report carries substantial doubt about the company's ability to continue as a going concern.
  • The trust floor protects only holders who properly exercise redemption rights before the deadline. Open-market buyers who miss it have no floor; the $7.90 print on 29 July shows the market does not enforce one.

Conclusion

Future Vision II's headline gain obscures what actually happened this week: a crash to 28% below trust value after the company admitted its Nasdaq listing approval hadn't arrived, followed by a partial recovery back toward cash value. At $11.00 against trust of $10.97, the stock offers almost no speculative premium, this is a SPAC pricing itself near Liquidation value , not one riding deal optimism. The redemption arithmetic is the real risk: with 65.4% of shares already tendered, remaining trust cash may not clear Nasdaq's listing threshold. Three dates now matter, August 13, August 26, and September 13, and any of them could end differently than planned.

This article is for informational purposes only and does not constitute Investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.